Free Trial
NYSE:AVTR

Avantor Q3 2025 Earnings Report

Avantor logo
$14.28 +0.51 (+3.67%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$14.34 +0.06 (+0.46%)
As of 10/3/2025 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avantor EPS Results

Actual EPS
N/A
Consensus EPS
$0.23
Beat/Miss
N/A
One Year Ago EPS
N/A

Avantor Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.65 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Avantor Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, October 29, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Avantor Earnings Headlines

Avantor (AVTR) Stock Is Up, What You Need To Know
URGENT: The Market's 3 Red Flags Are Flashing
Here’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.tc pixel
Avantor Appoints Gregory Lucier to Board of Directors
See More Avantor Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avantor? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avantor and other key companies, straight to your email.

About Avantor

Avantor (NYSE:AVTR) (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments. The first, Life Sciences, serves pharmaceutical, biotechnology and academic research institutions with analytical instrumentation, reagents and laboratory supplies for drug discovery, development and quality control. The second, Chemicals & Specialized Services, provides advanced materials, custom chemical synthesis and process technologies to semiconductor, aerospace, electronics and industrial markets.

Founded through the combination of established chemical suppliers dating back to the early 20th century, Avantor adopted its current name in 2011 and has since expanded through strategic acquisitions and organic growth. The company completed its initial public offering in 2019. Avantor is led by President and Chief Executive Officer Michael Stubblefield, who joined the company in 2022 with extensive experience in global manufacturing and technology sectors.

With operations in more than 180 countries, Avantor maintains a network of manufacturing facilities, distribution centers and research support centers across North America, Europe, Asia Pacific and Latin America. The company emphasizes stringent quality standards, regulatory compliance and sustainability initiatives to ensure reliable supply chains and to advance scientific innovation worldwide.

View Avantor Profile

More Earnings Resources from MarketBeat